Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients
- 1 April 2002
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 61 (4) , 1453-1461
- https://doi.org/10.1046/j.1523-1755.2002.00253.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetesAmerican Journal of Kidney Diseases, 2001
- Nephropathy in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 1999
- Renal replacement therapy for end-stage renal failure in France: Current status and evolutive trends over the last decadeAmerican Journal of Kidney Diseases, 1995
- The human cystatin C gene promoter: Functional analysis and identification of heterogeneous mRNAScandinavian Journal of Clinical and Laboratory Investigation, 1995
- Measuring progression of diabetic nephropathyEuropean Journal of Clinical Investigation, 1994
- The blood serum concentration of cystatin C (γ-trace) as a measure of the glomerular filtration rateScandinavian Journal of Clinical and Laboratory Investigation, 1985
- Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset DiabetesNew England Journal of Medicine, 1984
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- THE MEASUREMENT OF GLOMERULAR FILTRATION-RATE IN RENAL DISEASEThe Lancet, 1969
- Microglobulinaemia in Renal FailureNature, 1968